SHILPA MEDICARE LTD. - 530549 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Baring India Private Equity Fund III Ltd & Baring India Private Equity Fund III Listed Investments Ltd SHILPA MEDICARE LTD. - 530549 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 03, 2020 for Omprakash Inani SHILPA MEDICARE LTD. - 530549 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 02, 2020 for Omprakash Inani SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company had organized a group call with Analysts / Institutional Investors via Audio/Visual Means on Wednesday, 02nd September, 2020, the meeting was represented by Mr. Vishnukant Bhutada, Managing Director of the Company. The meeting held was general investors call. SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We wish to inform you that pursuant to the Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the schedule of Analysts / Investors meeting will be held on Wednesday i.e. on 02nd September, 2020 through audio-Video Conference. SHILPA MEDICARE LTD. - 530549 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Omprakash Inani & PACs SHILPA MEDICARE LTD. - 530549 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Omprakash Inani & PACs SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company had organized a group call with Analysts / Institutional Investors via Zoom Meetings on Thursday, 27th August, 2020, the meeting was represented by Mr. Vishnukant Bhutada, Managing Director of the Company. The meeting held was general investors call. SHILPA MEDICARE LTD. - 530549 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 27, 2020 for Ramakant Inani SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We wish to inform you that pursuant to the Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the schedule of Analysts / Investors meeting will be held on Thursday i.e on 27th August, 2020 through Video Conference.